KR0150634B1 - 5-치환된 오르니틴 유도체 및 이를 함유하는 약제학적 조성물 - Google Patents
5-치환된 오르니틴 유도체 및 이를 함유하는 약제학적 조성물 Download PDFInfo
- Publication number
- KR0150634B1 KR0150634B1 KR1019890001267A KR890001267A KR0150634B1 KR 0150634 B1 KR0150634 B1 KR 0150634B1 KR 1019890001267 A KR1019890001267 A KR 1019890001267A KR 890001267 A KR890001267 A KR 890001267A KR 0150634 B1 KR0150634 B1 KR 0150634B1
- Authority
- KR
- South Korea
- Prior art keywords
- acid
- solution
- ornithine
- mixture
- ether
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 0 *C(CCCOC(c1ccccc1)=O)N Chemical compound *C(CCCOC(c1ccccc1)=O)N 0.000 description 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/26—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one amino group bound to the carbon skeleton, e.g. lysine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/30—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and unsaturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Epidemiology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP88400275,9 | 1988-02-05 | ||
| US88400275,9 | 1988-02-05 | ||
| EP88400275A EP0326766B1 (en) | 1988-02-05 | 1988-02-05 | 5-substituted ornithine derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR890012942A KR890012942A (ko) | 1989-09-20 |
| KR0150634B1 true KR0150634B1 (ko) | 1998-10-15 |
Family
ID=8200349
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019890001267A Expired - Fee Related KR0150634B1 (ko) | 1988-02-05 | 1989-02-03 | 5-치환된 오르니틴 유도체 및 이를 함유하는 약제학적 조성물 |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US4902719A (enExample) |
| EP (1) | EP0326766B1 (enExample) |
| JP (1) | JP2816431B2 (enExample) |
| KR (1) | KR0150634B1 (enExample) |
| CN (1) | CN1027891C (enExample) |
| AR (1) | AR244657A1 (enExample) |
| AT (1) | ATE77367T1 (enExample) |
| AU (1) | AU612229B2 (enExample) |
| CA (1) | CA1311767C (enExample) |
| DE (1) | DE3872213T2 (enExample) |
| DK (1) | DK172113B1 (enExample) |
| ES (1) | ES2041815T3 (enExample) |
| FI (1) | FI90530C (enExample) |
| GR (1) | GR3005551T3 (enExample) |
| HU (1) | HU204770B (enExample) |
| IE (1) | IE63162B1 (enExample) |
| IL (1) | IL89145A (enExample) |
| NO (1) | NO176242C (enExample) |
| NZ (1) | NZ227783A (enExample) |
| PH (1) | PH26422A (enExample) |
| PT (1) | PT89637B (enExample) |
| ZA (1) | ZA89833B (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69132363T2 (de) * | 1990-04-26 | 2001-03-29 | Procter & Gamble | Chelat-zubereitung, die alpha-diamin-verbindungen enthalten |
| EP0609630A1 (en) * | 1993-02-05 | 1994-08-10 | Merrell Dow Pharmaceuticals Inc. | Use of inhibitors of ornithine aminotransferase for the manufacture of a medicament for the treatment of Alzheimer's disease |
| US5677350A (en) * | 1995-06-07 | 1997-10-14 | Wisconsin Alumni Research Foundation | Inhibition of cancer cell growth, proliferation, and metastasis using N,N'-dα,ω-diaminoalkanes |
| GB9617822D0 (en) * | 1996-08-27 | 1996-10-09 | Lilly Industries Ltd | Pharmaceutical compounds |
| US6566330B1 (en) | 1996-10-22 | 2003-05-20 | Medical University Of South Carolina Foundation Research Development | Positively charged non-natural amino acids, methods of making and using thereof in peptides |
| US6043218A (en) * | 1996-10-22 | 2000-03-28 | Medical University Of South Carolina | Positively charged non-natural amino acids, methods of making thereof, and use thereof in peptides |
| US7166234B1 (en) * | 2000-10-26 | 2007-01-23 | Integrated Biomedical Technology, Inc. | Dialdehyde assay |
| US6911544B2 (en) * | 2002-10-23 | 2005-06-28 | Pfizer Inc. | Process for the preparation of (S,S)-cis-2-phenyl-3-aminopiperidine |
| JP5994947B2 (ja) | 2013-10-21 | 2016-09-21 | 富士電機株式会社 | 制御系設計支援装置、制御系設計支援プログラム、制御系設計支援方法、操作変化量算出装置および制御装置 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1091661A (en) * | 1977-07-11 | 1980-12-16 | Philippe Bey | .alpha.-HALOMETHYL DERIVATIVES OF .alpha.-AMINO ACIDS |
| US4326071A (en) * | 1977-09-28 | 1982-04-20 | Merrell Toraude Et Compagnie | Halomethyl derivatives of gamma-aminobutyric acid and related compounds |
| ZA813953B (en) * | 1980-06-16 | 1982-06-30 | Merrell Dow Pharma | Method of inhibiting the growth of protozoa |
| US4668703A (en) * | 1983-07-07 | 1987-05-26 | Syntex (U.S.A.) Inc. | γ-allenyl-γ-aminobutyric acids |
-
1988
- 1988-02-05 EP EP88400275A patent/EP0326766B1/en not_active Expired - Lifetime
- 1988-02-05 AT AT88400275T patent/ATE77367T1/de not_active IP Right Cessation
- 1988-02-05 ES ES198888400275T patent/ES2041815T3/es not_active Expired - Lifetime
- 1988-02-05 DE DE8888400275T patent/DE3872213T2/de not_active Expired - Lifetime
-
1989
- 1989-01-30 AR AR89313107A patent/AR244657A1/es active
- 1989-01-30 CA CA000589568A patent/CA1311767C/en not_active Expired - Lifetime
- 1989-01-30 NZ NZ227783A patent/NZ227783A/en unknown
- 1989-01-31 PH PH38131A patent/PH26422A/en unknown
- 1989-02-01 FI FI890477A patent/FI90530C/fi not_active IP Right Cessation
- 1989-02-01 US US07/305,247 patent/US4902719A/en not_active Expired - Lifetime
- 1989-02-01 AU AU29515/89A patent/AU612229B2/en not_active Expired
- 1989-02-02 ZA ZA89833A patent/ZA89833B/xx unknown
- 1989-02-02 IL IL89145A patent/IL89145A/xx not_active IP Right Cessation
- 1989-02-03 DK DK051589A patent/DK172113B1/da not_active IP Right Cessation
- 1989-02-03 IE IE35689A patent/IE63162B1/en not_active IP Right Cessation
- 1989-02-03 HU HU89547A patent/HU204770B/hu not_active IP Right Cessation
- 1989-02-03 PT PT89637A patent/PT89637B/pt active IP Right Revival
- 1989-02-03 JP JP1024153A patent/JP2816431B2/ja not_active Expired - Lifetime
- 1989-02-03 KR KR1019890001267A patent/KR0150634B1/ko not_active Expired - Fee Related
- 1989-02-03 NO NO890455A patent/NO176242C/no unknown
- 1989-02-04 CN CN89100646A patent/CN1027891C/zh not_active Expired - Fee Related
-
1992
- 1992-08-27 GR GR920401882T patent/GR3005551T3/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5819954B2 (ja) | 抗炎症剤、免疫調節剤及び抗増殖剤としての化合物の新規カルシウム塩 | |
| US3784697A (en) | Pharmaceutical composition containing phenoxyalkane-carboxylic acids,salts and esters thereof | |
| JPH0472839B2 (enExample) | ||
| Kolb et al. | Synthesis and evaluation of mono-, di-, and trifluoroethenyl-GABA derivatives as GABA-T inhibitors | |
| KR0150634B1 (ko) | 5-치환된 오르니틴 유도체 및 이를 함유하는 약제학적 조성물 | |
| JP2870925B2 (ja) | 脂肪族2‐ヒドロキシ酸と1‐ベンジル‐3‐ヒドロキシメチル‐インダゾールのエーテル | |
| EP0147475B1 (en) | Aminocyclohexanol derivatives having an expectorant activity, process for their preparation and pharmaceutical compositions containing them | |
| PL84190B1 (en) | 3-aroyl-alkenyleneimines[us3835149a] | |
| JPS6251A (ja) | シス,エンド−2−アザビシクロ〔3.3.0〕オクタン−3−カルボン酸誘導体およびその製法 | |
| NO161853B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzamidforbindelser. | |
| KR0181945B1 (ko) | N,n'-비스(알콕시알킬)-피리딘-2,4-디카복실산 디아미드, 이의 제조방법 및 이를 함유하는 약제학적 조성물 | |
| FI113167B (fi) | Menetelmä osteoartikulaaristen sairauksien hoidossa käyttökelpoisten N-[(4,5-dihydroksi- ja 4,5,8-trihydroksi-9,10-dihydro-9,10-diokso-2-antrasenyyli)karbonyyli]aminohappojen valmistamiseksi | |
| JPS6399057A (ja) | グリシン誘導体 | |
| JPS5892646A (ja) | ベンジリデン誘導体 | |
| EP0155524A1 (en) | -Omega-aryl-alkylthienyl compounds, process for their preparation and pharmaceutical products containing these compounds | |
| FR2572405A1 (fr) | Nouveaux derives de la phenethylaminoalcoyle-6 furo-(3,4-c)-pyridine et leur procede de preparation | |
| JP2003533506A5 (ja) | システインカテプシン阻害剤としてのn-置換ペプチジルニトリル | |
| FR2571965A1 (fr) | Medicaments a base de nouveaux derives de la 4 h-dioxino-(4,5-c)-pyridine. | |
| NZ223805A (en) | Preparation of optically active oxo-isoindolinyl derivatives, and pharmaceutical compositions containing them | |
| JPH0812656A (ja) | ヘキサヒドロアゼピノンおよびヘキサヒドロアゼピノールの製造方法 | |
| JPH0445509B2 (enExample) | ||
| FR2670208A1 (fr) | Derives de phenyl-1 dihydro 1-4 arylalcoylamino-3 oxo-4 pyridazines, leur preparation et leur application en therapeutique. | |
| JPS61140549A (ja) | 10,11‐ジヒドロ‐5H‐ジベンゾ〔a,d〕シクロヘプタジエン誘導体、その製法及び該化合物を含有する薬剤 | |
| EP0091078A1 (en) | A process for the preparation of derivatives of 2-diethylamino-1-methyl ethyl cis-1-hydroxy-(bicyclohexyl)-2-carboxylate | |
| JPH0327357A (ja) | 新規環状アントラニル酸誘導体及びその製造法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0109 | Patent application |
St.27 status event code: A-0-1-A10-A12-nap-PA0109 |
|
| R17-X000 | Change to representative recorded |
St.27 status event code: A-3-3-R10-R17-oth-X000 |
|
| PG1501 | Laying open of application |
St.27 status event code: A-1-1-Q10-Q12-nap-PG1501 |
|
| A201 | Request for examination | ||
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| PA0201 | Request for examination |
St.27 status event code: A-1-2-D10-D11-exm-PA0201 |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
St.27 status event code: A-1-2-D10-D21-exm-PE0902 |
|
| T11-X000 | Administrative time limit extension requested |
St.27 status event code: U-3-3-T10-T11-oth-X000 |
|
| T11-X000 | Administrative time limit extension requested |
St.27 status event code: U-3-3-T10-T11-oth-X000 |
|
| T11-X000 | Administrative time limit extension requested |
St.27 status event code: U-3-3-T10-T11-oth-X000 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| E701 | Decision to grant or registration of patent right | ||
| PE0701 | Decision of registration |
St.27 status event code: A-1-2-D10-D22-exm-PE0701 |
|
| GRNT | Written decision to grant | ||
| PR0701 | Registration of establishment |
St.27 status event code: A-2-4-F10-F11-exm-PR0701 |
|
| PR1002 | Payment of registration fee |
St.27 status event code: A-2-2-U10-U11-oth-PR1002 Fee payment year number: 1 |
|
| PG1601 | Publication of registration |
St.27 status event code: A-4-4-Q10-Q13-nap-PG1601 |
|
| PN2301 | Change of applicant |
St.27 status event code: A-5-5-R10-R13-asn-PN2301 St.27 status event code: A-5-5-R10-R11-asn-PN2301 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 4 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 5 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 6 |
|
| FPAY | Annual fee payment |
Payment date: 20040609 Year of fee payment: 7 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 7 |
|
| LAPS | Lapse due to unpaid annual fee | ||
| PC1903 | Unpaid annual fee |
St.27 status event code: A-4-4-U10-U13-oth-PC1903 Not in force date: 20050617 Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE |
|
| PC1903 | Unpaid annual fee |
St.27 status event code: N-4-6-H10-H13-oth-PC1903 Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE Not in force date: 20050617 |
|
| P22-X000 | Classification modified |
St.27 status event code: A-4-4-P10-P22-nap-X000 |